/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

BIOMEA FUSION INC Share Price Today: Live Updates & Key Insights

BIOMEA FUSION INC share price today is $1.12, up 4.59%. The stock opened at $1.13 against the previous close of $1.09, with an intraday high of $1.15 and low of $1.105.

BIOMEA FUSION INC Share Price Chart

style
pb-0

BIOMEA FUSION INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

BIOMEA FUSION INC Share Price Performance

$1.12 0.0459(4.59%) BMEA at 23 Mar 2026 12:15 PM Biotechnology
Lowest Today 1.105
Highest Today 1.15
Today’s Open 1.13
Prev. Close 1.09
52 Week High 3.08
52 Week Low 0.87
Day’s Range: Low 1.105 High 1.15
52-Week Range: Low 0.87 High 3.08
1 day return -
1 Week return -9.52
1 month return -10.58
3 month return -14.6
6 month return -44.11
1 year return -59.06
3 year return -92.4
5 year return -93.81
10 year return -

BIOMEA FUSION INC Institutional Holdings

FMR Inc 12.47

Fidelity Growth Compy Commingled Pl S 5.55

Cormorant Asset Management, LLC 5.05

Vanguard Group Inc 4.20

Fidelity Growth Company Fund 3.84

Aisling Capital Management LP 2.90

Vanguard Total Stock Mkt Idx Inv 2.67

Woodline Partners LP 1.84

Marshall Wace Asset Management Ltd 1.64

Fidelity Growth Company K6 1.30

BlackRock Inc 1.28

Fidelity Series Growth Company 1.14

Vanguard Institutional Extnd Mkt Idx Tr 0.90

Fideuram - Intesa Sanpaolo Private Banking Spa 0.89

Mariner Wealth Advisors LLC 0.83

Federated Hermes Inc 0.81

Geode Capital Management, LLC 0.80

Renaissance Technologies Corp 0.68

Susquehanna International Group, LLP 0.68

Fidelity Select Biotechnology 0.64

Morgan Stanley - Brokerage Accounts 0.63

Two Sigma Investments LLC 0.60

Fidelity Extended Market Index 0.42

Federated Hermes MDT SCC Institutional 0.41

Federated Hermes MDT Small Cap Core IS 0.41

The Goldman Sachs Group Inc 0.38

XTX Topco Ltd 0.38

SUPERSTRING CAPITAL MANAGEMENT LP 0.35

Northern Trust Corp 0.27

iShares Micro-Cap ETF 0.23

Blackrock Extended Mkt Fund CF 0.21

State Street Corp 0.20

Extended Equity Market Fund K 0.18

Fidelity Total Market Index 0.15

Fidelity Series Total Market Index 0.10

Bridgeway Ultra-Small Company Market 0.10

NT Ext Equity Mkt Idx Fd - L 0.10

Spartan Extended Market Index Pool F 0.09

NT Ext Equity Mkt Idx Fd - NL 0.08

Vanguard Instl Ttl Stck Mkt Idx Tr 0.07

BIOMEA FUSION INC Market Status

Strong Buy: 4

Buy: 3

Hold: 2

Sell: 0

Strong Sell: 0

BIOMEA FUSION INC Fundamentals

Market Cap 80.60 M

PB Ratio 5.1605

PE Ratio 0.0

Enterprise Value 40.84 M

Total Assets 79.94 M

Volume 984897

BIOMEA FUSION INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-107685000 -107.7M, FY22:-80022000 -80.0M, FY21:-41218000 -41.2M, FY20:-5324000 -5.3M, FY19:-1198000 -1.2M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-400000 -0.4M, Q2/2025:-500000 -0.5M, Q1/2025:null 0.0M, Q3/2024:-400000 -0.4M, Q2/2024:-400000 -0.4M

Quarterly Net worth Q3/2025:-16407000 -16.4M, Q2/2025:-20740000 -20.7M, Q1/2025:-29262000 -29.3M, Q3/2024:-32787000 -32.8M, Q2/2024:-37276000 -37.3M

About BIOMEA FUSION INC & investment objective

Company Information Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States. It's lead product candidate icovamenib, an orally bioavailable, potent, and covalent inhibitor of menin, a ubiquitously expressed scaffold protein that functions in histone modification and epigenetic gene regulation to impact multiple cellular processes including cell cycle control, apoptosis, and DNA damage repair. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in San Carlos, California.

Organisation Biotechnology

Employees 42

Industry Biotechnology

CEO Dr. Michael J. M. Hitchcock Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

BIOMEA FUSION INC FAQs

What is the share price of BIOMEA FUSION INC today?

The current share price of BIOMEA FUSION INC is $1.12.

Can I buy BIOMEA FUSION INC shares in India?

Yes, Indian investors can buy BIOMEA FUSION INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy BIOMEA FUSION INC shares in India?

You can easily invest in BIOMEA FUSION INC shares from India by:

Can I buy fractional shares of BIOMEA FUSION INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BIOMEA FUSION INC?

BIOMEA FUSION INC has a market cap of $80.60 M.

In which sector does BIOMEA FUSION INC belong?

BIOMEA FUSION INC operates in the Biotechnology sector.

What documents are required to invest in BIOMEA FUSION INC stocks?

To invest, you typically need:

What is the PE and PB ratio of BIOMEA FUSION INC?

The PE ratio of BIOMEA FUSION INC is N/A and the PB ratio is 5.16.